Matthew D. Morgan

Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis

Rachel Jones, Jan Willem Cohen Tervaert, Thomas Häuser et al. · New England Journal of Medicine · 2010 · 1.7K citations · Full text

Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up

Lorraine Harper, Matthew D. Morgan, Michael Walsh et al. · Annals of the Rheumatic Diseases · 2011 · 424 citations

Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial

Rachel Jones, Shunsuke Furuta, Jan Willem Cohen Tervaert et al. · Annals of the Rheumatic Diseases · 2015 · 263 citations · Full text

Fifteen-Year Survival of Endoscopic Anterior Cruciate Ligament Reconstruction in Patients Aged 18 Years and Younger

Matthew D. Morgan, Lucy J. Salmon, Alison Waller et al. · The American Journal of Sports Medicine · 2016 · 172 citations

Prediction of ESRD and Death Among People With CKD: The Chronic Renal Impairment in Birmingham (CRIB) Prospective Cohort Study

Martin Landray, Jonathan Emberson, Lisa Blackwell et al. · American Journal of Kidney Diseases · 2010 · 167 citations · Full text